Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of NWRD09 in HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

NCT06741150 is registered in ClinicalTrials.gov with Newish Technology (Beijing) Co., Ltd. as lead sponsor.

NCT NCT06741150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06741150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of NWRD09 in HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
Lead sponsor
Newish Technology (Beijing) Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
June 24, 2024
Completion date
December 31, 2025
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, intraepithelial neoplasia